Validating AI for Visual Inspection

Register for an Upcoming Session

Artificial Intelligence is everywhere. In January 2025 the FDA released – Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry and Other Interested Parties. PBL and ProPharma unlock the mysteries of how AI works in visual inspection and provides insights into how to utilize A.I. technology to inspect and release GxP products in a compliant way.

In this is a free webinar, you will learn how Artificial Intelligence is utilized to detect foreign materials in pharmaceutical and biological applications as well as the methodology you need to apply to comply with regulatory requirements.

Validating AI for Visual Inspection Topics

  • Why AI is critical to assure safe drug supply
  • How AI for Visual Inspection is implemented on IV bags and non-standard products
  • How Visual Inspection with AI is validated per regulatory requirements
  • Modifications required for AI to analyze difficult products including blood
  • Considerations to resolve challenges of AI for blood, cell and gene therapies